CHAIN Biotech

DualTPharma

This company develops bacteria-based drug delivery systems to transport immunotherapies into solid tumours for cancer patients.

Exomnis Biotech

This company develops engineered bacteria as delivery vehicles for cancer immunotherapies, serving pharmaceutical companies and clinical researchers.

Neobe

The company develops engineered microbial biotherapeutics designed to disrupt the microenvironment of solid tumours for cancer patients receiving immunotherapy.

Bactheravax

This company develops therapeutic vaccines targeting tumour-associated bacteria to improve treatment sensitivity and immune responses for patients with colorectal and other cancers.

mbiomics

This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.

Microbiotica

This company develops live bacterial therapeutics and biomarkers for patients with inflammatory bowel disease and advanced melanoma.

General Biotechnologies

This company develops genetically programmed edible microbes to manufacture oral peptide therapeutics for patients with metabolic diseases and other chronic conditions.

Biograil

This biotech company develops a capsule device that enables oral delivery of injectable biologic drugs for pharmaceutical firms and patients.